NFX

Two NFX FAST funding competitions are open! -NFX FAST Forward: for Israeli startups in space, cyber, defense tech, DevOps AI, longevity, fintech, & vertical AI. -NFX Longevity FAST: for scientist-founders focused on aging. $1.5M - $3M SAFE investment depending on FAST type. Decisions in 9 days. Applications and details below: FAST is a new SLA for fundraising. -$20M allocated. First come, First serve? -Money in your bank in 3 weeks? -A simple financial contract? -Transparent process Apply to NFX FAST Forward: https://lnkd.in/es36WrNC Apply to NFX Longevity FAST: https://lnkd.in/eHJyNtmc

FAST LITE is officially open! FAST LITE is a funding competition open to students/alumni from from Harvard, Stanford, Berkeley, and MIT. Winners receive $50-$100K checks and feedback on their ideas from NFX partners. Apply below: Harvard FAST Lite: bit.ly/harvardfastlite Stanford FAST Lite: bit.ly/stanfordfastlite Berkeley FAST Lite: bit.ly/berkeleyfastlite MIT FAST Lite: bit.ly/mitfastlite

Meet the 2025 NFX Fellows. From a pool of 300+ applicants from Stanford, Berkeley, MIT, and Harvard, we've chosen top operators and investors ready to back their peers at the earliest stage. This year, we're going to hit the ground running... https://lnkd.in/eC8erJmT This Friday (11/1) we're launching FAST LITE: an early version of our spring FAST competition. Winners receive $50K – $100K checks, and the opportunity to receive feedback from NFX Partners. FAST LITE is designed to support student/alumni founders from Harvard, Stanford, Berkeley and MIT with ideas at the earliest stages. Applications open 11/1. Watch this space for updates. Get up to speed on FAST LITE in our post above. Or reach out to an NFX Fellow to learn more.?

The bar for raising series A as a techbio platform is high. You have to have a strategy. The key is to balance platform + asset development. One propels the other. Omri Amirav-Drory's tactics for reaching key Series A milestones as a bioplatform: https://lnkd.in/eMEHKCdp

Congratulations to our portco Centivax on advancing Cent-Flu, their universal flu vaccine, into GMP manufacturing. Cent-Flu aims to protect against all past, present, and future influenza strains This is a critical critical milestone in the fight against infectious disease. Congrats again to the whole team: https://lnkd.in/djUSwUiH

Please join us in congratulating Daniel Museles on his promotion to Principal at NFX. Daniel will probably find you first, but if you’re working on something early and wacky, reach out to him! https://lnkd.in/dPXZy3qf

The best investors "see what others do not" because they have a fresh POV. Where would tech be without builders-turned-investors? Would TechBio exist without scientist-investors? A candid take from Omri Amirav-Drory why more investors = more breakthroughs: https://lnkd.in/eTqEJzVv

Horizontal SaaS is vulnerable. Poor UX, and commoditized infrastructure are the weak spots. AI-powered vertical solutions will unbundle major B2B categories. Pete Flint on why startups will drive the "Verticalization of Everything:" https://lnkd.in/ec_km9Zu

Software with a Soul (SwaS): AI where humanness is the core value proposition. It has emotional intelligence, creativity, empathy, stochasticity. It may even feel like an expansion of yourself. This is where AI is headed, from Anna Pi?ol: https://lnkd.in/eiyAqk46?

Congratulations to Roee Farber and the team at ZipBio! The NFX team is so proud to be on this journey with you. https://lnkd.in/gVsM7GUM